Global Ultrasound Bone Sonometers Market Strategic Research Report

Scope of the Report

The global Ultrasound Bone Sonometers market size is predicted to grow from US$ 2,314 million in 2025 to US$ 3,184 million in 2032; it is expected to grow at a CAGR of 4.4% from 2026 to 2032.

Ultrasound bone sonometers refer to medical devices that use quantitative ultrasound (QUS) technology to perform non-invasive testing of peripheral bones such as the calcaneus to assess bone mineralization and fracture risk. Represented by Hologic's Sahara clinical bone sonometer and GE Healthcare's Lunar Achilles series, these devices measure the speed of sound (SOS) and broadband ultrasound attenuation (BUA) in the calcaneus, synthesizing the results into parameters such as the "stiffness index." These, along with T-scores and Z-scores, provide a basis for osteoporosis diagnosis and fracture risk assessment.

Unlike traditional dual-energy X-ray absorptiometry (DXA), ultrasound bone mineral density testing does not use ionizing radiation. The devices are small, portable, and suitable for deployment in outpatient clinics, community screening sites, and pharmacies. Multiple studies have described it as a safe, easy-to-use tool for rapid bone health assessment in peripheral bones.

In 2025, global Ultrasound Bone Sonometer sales reached approximately 201 K Units, with an average global market price of around 11,785 US$/Units. Production capacity reached 250 K Units, with a gross profit margin of approximately 40%.

Upstream in the Ultrasound Bone Sonometers industry chain, the core components are ultrasonic transducers, piezoelectric ceramic materials, precision analog/digital front-ends, and embedded computing and signal processing modules. QUS devices need to simultaneously and accurately measure sound velocity and broadband attenuation, while controlling parameters such as heel temperature and coupling medium state to ensure repeatability and comparability. Therefore, system integrators typically develop their own measurement and imaging algorithms based on general-purpose electronic components, industrial PCs, or dedicated embedded platforms.

Downstream, the core is hospitals, imaging centers, health check-up institutions, and primary healthcare facilities, and in recent years, this has gradually extended to pharmacies and mobile screening services. The Hologic Sahara, approved by the FDA for quantitative ultrasound measurement of the calcaneus, supplemented by other clinical risk factors, serves as an auxiliary tool for osteoporosis diagnosis and fracture risk assessment, described as a "simple dry ultrasound solution suitable for outpatient and office use." The GE Lunar Achilles series, as a portable peripheral bone mineral density device, is used for rapid population screening at health exhibitions and screening projects in multiple countries.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Ultrasound Bone Sonometers market?

What factors are driving Ultrasound Bone Sonometers market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Ultrasound Bone Sonometers market opportunities vary by end market size?

How does Ultrasound Bone Sonometers break out by Type, by Application?

This report presents a comprehensive overview of the global Ultrasound Bone Sonometers market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

• DEXA
• Ultrasound
• Others

Segment by Product Form

• Portable
• Desktop/Vehicle-Mounted

Segment by Measurement Site

• Calcaneal Bone Sonometers
• Tibial/Radial Bone Sonometers

Segment by Application

• Hospital
• Clinical
• Health Center
• Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Ultrasound Bone Sonometers market:

• Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
• Distributors, channel partners and end users in Hospital, Clinical, Health Center evaluating demand and sourcing options
• Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
• Government agencies, industry associations and research institutions tracking industry developments and policy impact